Kanwal Gill

Kanwal Gill is a Principal Scientist at Pfizer, based in Andover, MA. She is member of the Pharmaceutical Research and Development (PhRD) group within Pfizer's Biotherapeutics Pharmaceutical Sciences organization. Her academic background is rooted in the formulation aspects of drug development; however, she has dedicated significant portions of both her doctoral studies and industrial career in Merck, GSK & Novartis to developing analytical methods for various drug modalities. Kanwal joined Pfizer in 2019 and led PhRD's mRNA analytical team during Pfizer's Covid-19 response efforts where she also spearheaded the initiatives of developing novel automated solutions to meet the unprecedented demands of accelerated timelines in mRNA-LNP development.